5-157163061-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_130899.3(GARIN3):āc.1204T>Gā(p.Leu402Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000502 in 1,614,218 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_130899.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GARIN3 | NM_130899.3 | c.1204T>G | p.Leu402Val | missense_variant | 2/2 | ENST00000302938.4 | NP_570969.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARIN3 | ENST00000302938.4 | c.1204T>G | p.Leu402Val | missense_variant | 2/2 | 1 | NM_130899.3 | ENSP00000305596 | P1 | |
ITK | ENST00000521769.5 | c.-296-3027A>C | intron_variant | 4 | ENSP00000430327 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000717 AC: 18AN: 251130Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135752
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1461890Hom.: 0 Cov.: 33 AF XY: 0.0000248 AC XY: 18AN XY: 727248
GnomAD4 genome AF: 0.000295 AC: 45AN: 152328Hom.: 0 Cov.: 33 AF XY: 0.000309 AC XY: 23AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2023 | The c.1204T>G (p.L402V) alteration is located in exon 2 (coding exon 2) of the FAM71B gene. This alteration results from a T to G substitution at nucleotide position 1204, causing the leucine (L) at amino acid position 402 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at